scholarly journals Effect of Transcutol and Stearylamine on Ibuprofen Hydrophilic Gel for Transdermal Delivery

Author(s):  
Mahdi Abd Zair ◽  
D. Prasanthi ◽  
Amoolya Chennuri ◽  
Zainab Rahi Hanthal ◽  
P K Lakshmi

Transdermal drug delivery system (TDDS) shows promising results when compared with oral drug delivery system mainly by eliminating the first pass metabolism and by improving the bioavailability of drug. Hydrophilic gels are networks of polymer chains that are sometimes found as colloidal gels in which water is the dispersion medium. Ibuprofen, nonsteroidal anti-inflammatory drug used to relieve pain, reduces fever and anti-inflammation. The purpose of present research is to demonstrate the influence of various enhancers (transcutol and stearylamine) in various concentrations on percutaneous permeation of ibuprofen hydrophilic gel from HPMC K4M & HPMC K100M gel formulation. Gelling agents at various concentrations were preliminary screened for gel consistency. The control and the prepared gels were evaluated for clarity, homogeneity, spreadability, extrudability, drug content, invitro diffusion, ex-vivo permeation, skin irritation, anti-inflammatory activity and stability studies. All formulations have shown better physicochemical properties. Ex-vivo skin permeation studies reveals that the (IBU29) formulated using HPMC K4M 6%, transcutol 40% and stearylamine 4% as permeation enhancers has shown maximum drug release of 86.4 % for 24hrs. Permeability parameters like flux were found to be 1940.68±0.06µg/cm²/hr, permeability coefficient was found 31 ×10-3 cm/hr and Q24 was found to be 5240.82±0.06µg/cm² and enhancement ratio of 13.06 over pure drug. Skin irritation studies showed irritation potential of “0” score thus providing to be non-irritant. The anti-inflammation studies were performed with inflammation induced by carrageenan 1% w/v solution. Optimized formulation (IBU29) showed highest reduction of inflammation comparable to marketed preparation BRUGESIC GEL®. The formulations were stable at room temperature for 1 month.Key words: Transdermal gel, Ibuprofen, HPMC K4M, HPMC K100M, Penetration- enhancer..

2021 ◽  
Vol 17 (5) ◽  
pp. 859-872
Author(s):  
Yingzhuo Song ◽  
Tao Zhang ◽  
Huiguang Cheng ◽  
Wei Jiang ◽  
Pu Li ◽  
...  

Osteoarthritis is one of the most prevalent chronic diseases. Cartilage inflammation in osteoarthritis results from pain in articular joints. Anti-inflammatory drugs provide relief by hindering the production of pro-inflammatory cytokines and interleukin-6. Targeted delivery of anti-inflammatory drugs is very effective in the treatment of osteoarthritis. This approach reduces the usage of therapeutic drug dosages and unwanted side effects. Here, we fabricated a non-invasive and efficient targeted drug delivery system to reduce persistent inflammation in an osteoarthritis model. Temperature-sensitive hollow dextran/poly(N-isopropyl acrylamide) nanoparticles were synthesized by the destruction of N,N’-bis(acryloyl)cystamine crosslinked cores in imidazolium-based ionic liquids. The copolymerized 2-acrylamido-2-methylpropane sulfonic acid created sulfur functionalities that increase the loading of therapeutic KAFAK peptides. The chemical structure of the polymer nanoparticles was analyzed with UV-Visible, Fourier transform infrared, and X-ray photoelectron spectroscopy. The thermal responsive characteristics of the nanoparticles were determined with dynamic light scattering, scanning electron microscopy, and transmission electron microscopy analyses. Moreover, the synthesized nanoparticles were used as drug carriers to reduce inflammation in an Ex Vivo osteoarthritis model. The KAFAK-loaded hollow dextran/PNIPAM nanoparticles effectively delivered therapeutic peptides in cartilage explants to suppress inflammation. These thermoresponsive nanoparticles could be an effective drug delivery system to deliver anti-inflammatory therapeutic peptides in a highly osteoarthritic environment.


2012 ◽  
Vol 9 (2) ◽  
pp. 213-217 ◽  
Author(s):  
Mehdi Rahimi ◽  
Hamid Mobedi ◽  
Aliasghar Behnamghader ◽  
Alireza Nateghi Baygi ◽  
Houri Mivehchi ◽  
...  

RSC Advances ◽  
2020 ◽  
Vol 10 (73) ◽  
pp. 45130-45138
Author(s):  
Li Li ◽  
Shasha Han ◽  
Sengqun Zhao ◽  
Xurui Li ◽  
Bingmi Liu ◽  
...  

The drug delivery system of CS-MOF@5-FU was developed to achieve oral administration of 5-FU.


Pharmaceutics ◽  
2020 ◽  
Vol 12 (6) ◽  
pp. 544
Author(s):  
Miao Wang ◽  
Sung-Kyun You ◽  
Hong-Ki Lee ◽  
Min-Gu Han ◽  
Hyeon-Min Lee ◽  
...  

Docetaxel (DTX) has clinical efficacy in the treatment of breast cancer, but it is difficult to develop a product for oral administration, due to low solubility and permeability. This study focused on preparing a self-microemulsifying drug delivery system (SME) loaded with DTX-phospholipid complex (DTX@PLC), to improve the dissolution and gastrointestinal (GI) permeability of DTX. A dual technique combining the phospholipid complexation and SME formulation described as improving upon the disadvantages of DTX has been proposed. We hypothesized that the complexation of DTX with phospholipids can improve the lipophilicity of DTX, thereby increasing the affinity of the drug to the cell lipid membrane, and simultaneously improving permeability through the GI barrier. Meanwhile, DTX@PLC-loaded SME (DTX@PLC-SME) increases the dissolution and surface area of DTX by forming a microemulsion in the intestinal fluid, providing sufficient opportunity for the drug to contact the GI membrane. First, we prepared DTX@PLC-SME by combining dual technologies, which are advantages for oral absorption. Next, we optimized DTX@PLC-SME with nanosized droplets (117.1 nm), low precipitation (8.9%), and high solubility (33.0 mg/g), which formed a homogeneous microemulsion in the aqueous phase. Dissolution and cellular uptake studies demonstrated that DTX@PLC-SME showed 5.6-fold higher dissolution and 2.3-fold higher DTX uptake in Caco-2 cells than raw material. In addition, an ex vivo gut sac study confirmed that DTX@PLC-SME improved GI permeability of DTX by 2.6-fold compared to raw material. These results suggested that DTX@PLC-SME can significantly overcome the disadvantages of anticancer agents, such as low solubility and permeability.


Sign in / Sign up

Export Citation Format

Share Document